Biotechnology Co., Ltd.: The shareholding ratio of the largest shareholder and its concerted parties passively increased to 14.06%.

Biotech Co. announced that due to the cancellation of the 2023 employee stock ownership plan on August 6, 2026, a total of 8.5184 million shares of the underlying stock corresponding to the granted but not yet unlocked equity shares will be cancelled, resulting in a decrease in the total share capital. Consequently, the combined shareholding percentage of the largest shareholder, Inner Mongolia Jinyu Biotechnology Holdings Co., Ltd., and its concerted actors will increase from 13.95% to 14.06%. This change in equity is a passive increase in the shareholder's holding ratio, does not involve subsequent disclosure work, and will not have a significant impact on the company's governance structure or its ongoing operations.